Search Results 71-80 of 17293 for hba1c

  1. Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    Patients with decompensated diabetes (HbA1c>9%). Patients with a history of clinically significant acute cardiac event within 6 months prior to screening ...

  2. Dietary Interventions in Prediabetes - Clinical Trials

    HbA1c 5.7-6.4 %; BMI 26-40 kg/sq.m. Exclusion Criteria: MRS contraindication; Pregnant women; Liver disease. Participating Mayo Clinic locations. Study statuses ...

  3. Bone and joint problems associated with diabetes - Mayo Clinic

    Certain factors, such as nerve damage (diabetic neuropathy), arterial disease and obesity, may cause these problems — but often the cause isn't clear. Learn ...

  4. Pasireotide S.c. In Patients With Post-Bariatric Hypoglycaemia - Mayo Clinic

    - With an HbA1c at screening <6.5% - Not taking any medications for hyperglycaemia for at least 3 months prior to screening. - Their qualifying Level 3 ...

  5. Shared Decision Making With Pharmaceutical Care - Mayo Clinic

    HbA1c of 7%-9.5% within past 6 months; Prescribed three or less anti-hyperglycemic medications as indicated by the medication list within the medical record.

  6. Shared Savings Program Public Reporting - Mayo Clinic

    *For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day,. All-Cause Unplanned Readmission (HWR) Rate for MIPS ...

  7. A Study of Nighttime Blood Sugar Control Patterns in Type 2 Diabetes - Mayo Clinic

    ... HbA1c of ≤ 10.%. Exclusion Criteria. Diabetics on insulin, glucagon-like peptide-1 based therapies or thiazolidinediones; Type 2 Diabetic subjects with ...

  8. Type 2 Diabetes Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the effectiveness of Revita® DMR for improving HbA1c to ≤ 7% without the need of insulin in subjects with T2D ...

  9. Dual-Hormone Control of Post-absorptive and Post-prandial Glucose in Type 1 Diabetes - Mayo Clinic

    HbA1c ≤ 10%; On insulin pump therapy for at least six months; no symptomatic gastroparesis; no unstable retinopathy (requiring photocoagulation within past 6 ...

  10. PACTAID App In Adults With Type 1 Diabetes To Help Manage Exercise - Mayo Clinic

    * CGM and insulin pump data available for \> 70% for last 2 weeks. * T1D without atherosclerotic cardiovascular disease * HbA1c ≤10 % * Able to understand ...